These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 2698224)

  • 1. Prostaglandin receptors in the cardiovascular system: potential selectivity from receptor subtypes or modified responsiveness.
    Keen M; Kelly E; MacDermot J
    Eicosanoids; 1989; 2(4):193-7. PubMed ID: 2698224
    [No Abstract]   [Full Text] [Related]  

  • 2. 7-Oxabicyclo[2.2.1]heptane analogs as modulators of the thromboxane A2 and prostacyclin receptors.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():337-43. PubMed ID: 6303073
    [No Abstract]   [Full Text] [Related]  

  • 3. Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors.
    Halushka PV; Mais DE; Saussy DL
    Fed Proc; 1987 Jan; 46(1):149-53. PubMed ID: 2948839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable carbocyclic analog of thromboxane A2 as antagonist of prostaglandin receptors.
    Shimizu K; Kohli JD; Goldberg LI; Kittisopikul S; Fried J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():333-6. PubMed ID: 6303072
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and evaluation of trimetoquinol derivatives: novel thromboxane A2/prostaglandin H2 antagonists with diminished beta-adrenergic agonist activity.
    Christoff JJ; Bradley L; Miller DD; Lei L; Rodriguez F; Fraundorfer P; Romstedt K; Shams G; Feller DR
    J Med Chem; 1997 Jan; 40(1):85-91. PubMed ID: 9016331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of thromboxane receptor antagonists in acute cardiovascular crises.
    Lefer AM
    Prog Clin Biol Res; 1987; 242():221-8. PubMed ID: 2959963
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
    J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of an 125I-labeled thromboxane A2/prostaglandin H2 receptor antagonist to washed canine platelets.
    Mais DE; Kochel PJ; Saussy DL; Halushka PV
    Mol Pharmacol; 1985 Aug; 28(2):163-9. PubMed ID: 2991736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies.
    Woodward DF; Lawrence RA; Fairbairn CE; Shan T; Williams LS
    J Lipid Mediat; 1993; 6(1-3):545-53. PubMed ID: 8358015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids.
    Sharif NA; Crider JY; Xu SX; Williams GW
    J Pharmacol Exp Ther; 2000 May; 293(2):321-8. PubMed ID: 10772998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of a thromboxane A2/prostaglandin H2 receptor antagonist to washed human platelets.
    Mais DE; Burch RM; Saussy DL; Kochel PJ; Halushka PV
    J Pharmacol Exp Ther; 1985 Dec; 235(3):729-34. PubMed ID: 3001275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin endoperoxide and thromboxane A2 analogs.
    Wilson NH; Jones RL
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 14():393-425. PubMed ID: 2992245
    [No Abstract]   [Full Text] [Related]  

  • 14. Thromboxane biosynthesis and antagonism in humans.
    FitzGerald GA; Fitzgerald DJ; Lawson JA; Murray R
    Adv Prostaglandin Thromboxane Leukot Res; 1987; 17A():199-203. PubMed ID: 2959047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of exogenous prostaglandins on the cardiovascular system].
    Alekseeva NP; Makoeva LD
    Sov Med; 1980; (2):96-101. PubMed ID: 6987749
    [No Abstract]   [Full Text] [Related]  

  • 16. Steric mapping of some prostaglandin receptor sites.
    Simon Z; Kerek F
    Acta Physiol Acad Sci Hung; 1982; 60(4):205-11. PubMed ID: 6314741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation.
    Hata AN; Breyer RM
    Pharmacol Ther; 2004 Aug; 103(2):147-66. PubMed ID: 15369681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of prostaglandin E2 and thromboxane A2 synthesis and suppression of PHA-stimulated peripheral blood mononuclear leucocytes.
    Awara W; Hillier K; Jones D
    Immunology; 1986 Dec; 59(4):557-62. PubMed ID: 3468061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZK 110 841--a selective and potent prostaglandin D2 analogue.
    Thierauch KH; Stürzebecher S; Schillinger E; Schulz G; Radüchel B; Skuballa W; Vorbrüggen H; Schulze PE
    Prog Clin Biol Res; 1989; 301():597-601. PubMed ID: 2798462
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostanoid receptor subtypes: new targets for OAB drugs?
    Andersson KE
    J Urol; 2009 Nov; 182(5):2099-100. PubMed ID: 19758658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.